Amicus Therapeutics Inc (FOLD)
9.80
-0.08
(-0.81%)
USD |
NASDAQ |
May 31, 16:00
9.82
+0.02
(+0.20%)
After-Hours: 20:00
Amicus Therapeutics Gross Profit (Quarterly): 96.84M for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 96.84M |
December 31, 2023 | 103.76M |
September 30, 2023 | 93.56M |
June 30, 2023 | 85.39M |
March 31, 2023 | 79.33M |
December 31, 2022 | 78.71M |
September 30, 2022 | 68.26M |
June 30, 2022 | 72.53M |
March 31, 2022 | 71.13M |
December 31, 2021 | 74.30M |
September 30, 2021 | 67.85M |
June 30, 2021 | 69.03M |
March 31, 2021 | 59.86M |
December 31, 2020 | 61.15M |
September 30, 2020 | 59.04M |
June 30, 2020 | 55.68M |
March 31, 2020 | 53.97M |
December 31, 2019 | 48.35M |
September 30, 2019 | 43.17M |
June 30, 2019 | 38.76M |
March 31, 2019 | 29.99M |
December 31, 2018 | 28.30M |
September 30, 2018 | 16.29M |
June 30, 2018 | 18.17M |
March 31, 2018 | 14.08M |
Date | Value |
---|---|
December 31, 2017 | 12.12M |
September 30, 2017 | 9.084M |
June 30, 2017 | 6.097M |
March 31, 2017 | 3.394M |
December 31, 2016 | 2.342M |
September 30, 2016 | 1.783M |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
38.76M
Minimum
Jun 2019
103.76M
Maximum
Dec 2023
69.03M
Average
68.64M
Median
Gross Profit (Quarterly) Benchmarks
Insmed Inc | 58.04M |
TG Therapeutics Inc | 58.03M |
Rhythm Pharmaceuticals Inc | 23.16M |
Alnylam Pharmaceuticals Inc | 428.36M |
InfuSystems Holdings Inc | 16.47M |